Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global soft tissue allografts market attained a value of USD 3.92 billion in 2020. The soft tissue allografts market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 7% to reach USD 5.9 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The soft tissue allografts market is driven by an increase in the frequency of orthopaedic surgeries and dental implants.
The soft tissue allografts are referred to as the substitute tissues used to reconstruct deficient ligaments, torn menisci, spinal surgery, and osteochondral defects during knee surgery. They undergo a three-stage safety screening process.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The soft tissue allografts industry is segmented based on types, applications, and end-uses.
Based on types, the industry is divided into:
Based on applications, the industry is segmented into:
Based on end-uses, the industry is divided into:
The EMR report looks into the regional markets of soft tissue allografts like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global soft tissue allografts market is driven by the rising opportunities as the number of procedures rise. The anterior cruciate ligament (ACL) reconstruction has found a common occurrence among sportspersons and is expected to fuel the market growth for soft tissue allografts. The market is further aided by the requirement for healthy teeth to invigorate the demand. The poor lifestyle of the population due to technology addicted lifestyle will provide impetus to the market growth.
The report presents a detailed analysis of the following key players in the global soft tissue allografts market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Application, End Use, Region |
Breakup by Type | Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Others |
Breakup by Application | Orthopaedic, Dentistry, Wound Care, Others |
Breakup by End Use | Hospitals, Aesthetic Centres, Orthopedic Clinics, Dental Clinics, Others |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Allergan [AGN (NYSE)], CONMED Corporation [CNMD (NASDAQ)], Xtant Medical [CNMD (NASDAQ)], Becton, Dickinson and Company [BDX (NYSE)], Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Soft Tissue Allografts Market Analysis
8.1 Key Industry Highlights
8.2 Global Soft Tissue Allografts Historical Market (2018-2022)
8.3 Global Soft Tissue Allografts Market Forecast (2023-2028)
8.4 Global Soft Tissue Allografts Market by Type
8.4.1 Cartilage Allograft
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Tendon Allograft
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Meniscus Allograft
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Dental Allograft
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Others
8.5 Global Soft Tissue Allografts Market by Application
8.5.1 Orthopaedic
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Dentistry
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Wound Care
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Soft Tissue Allografts Market by End Use
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Aesthetic Centres
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Orthopedic Clinics
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Dental Clinics
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Others
8.7 Global Soft Tissue Allografts Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Allergan [AGN (NYSE)]
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 CONMED Corporation [CNMD (NASDAQ)]
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Xtant Medical [CNMD (NASDAQ)]
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Becton, Dickinson and Company [BDX (NYSE)]
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Soft Tissue Allografts Market: Key Industry Highlights, 2018 and 2028
2. Global Soft Tissue Allografts Historical Market: Breakup by Type (USD Billion), 2018-2022
3. Global Soft Tissue Allografts Market Forecast: Breakup by Type (USD Billion), 2023-2028
4. Global Soft Tissue Allografts Historical Market: Breakup by Application (USD Billion), 2018-2022
5. Global Soft Tissue Allografts Market Forecast: Breakup by Application (USD Billion), 2023-2028
6. Global Soft Tissue Allografts Historical Market: Breakup by End Use (USD Billion), 2018-2022
7. Global Soft Tissue Allografts Market Forecast: Breakup by End Use (USD Billion), 2023-2028
8. Global Soft Tissue Allografts Historical Market: Breakup by Region (USD Billion), 2018-2022
9. Global Soft Tissue Allografts Market Forecast: Breakup by Region (USD Billion), 2023-2028
10. North America Soft Tissue Allografts Historical Market: Breakup by Country (USD Billion), 2018-2022
11. North America Soft Tissue Allografts Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Europe Soft Tissue Allografts Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Europe Soft Tissue Allografts Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Asia Pacific Soft Tissue Allografts Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Asia Pacific Soft Tissue Allografts Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Latin America Soft Tissue Allografts Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Latin America Soft Tissue Allografts Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Middle East and Africa Soft Tissue Allografts Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Middle East and Africa Soft Tissue Allografts Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Global Soft Tissue Allografts Market Structure
In 2020, the global soft tissue allografts market attained a value of nearly USD 3.92 billion.
The market is projected to grow at a CAGR of 7% between 2023 and 2028.
The market is being driven by the increased demand for anterior cruciate ligament (ACL) repair among athletes, growing demand for teeth health improvement solutions, rising musculoskeletal issues, and the sedentary lifestyle.
The key trends propelling the industry growth include the rising demand for orthopaedic procedures and dental implants.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The significant types include cartilage allograft, tendon allograft, meniscus allograft, dental allograft, and others.
The major applications include orthopaedic, dentistry, wound care, and others.
The different end uses include hospitals, aesthetic centres, orthopaedic clinics, dental clinics, and others.
The major players in the industry are Allergan [AGN (NYSE)], CONMED Corporation [CNMD (NASDAQ)], Xtant Medical [CNMD (NASDAQ)], Becton, Dickinson and Company [BDX (NYSE)], and others.
The global soft tissue allografts market attained a value of USD 3.92 billion in 2020, driven by a surge in the number of orthopaedic procedures and dental implants. Aided by the growing demand for efficient dental treatment solutions, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 7%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the global soft tissue allografts industry can be segmented into cartilage allograft, tendon allograft, meniscus allograft, dental allograft, and others. By application, the industry can be divided into orthopaedic, dentistry, wound care, and others. On the basis of end use, the market can be categorised into hospitals, aesthetic centres, orthopaedic clinics, dental clinics, and others. The major regional markets for soft tissue allografts are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific. The key players in the above market include Allergan [AGN (NYSE)], CONMED Corporation [CNMD (NASDAQ)], Xtant Medical [CNMD (NASDAQ)], Becton, Dickinson and Company [BDX (NYSE)], and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.